Recent Courses

World Arthritis Day and Global Implications of ‘Don’t Delay, Connect Today’
  • 0.25 AMA PRA Category 1 Credit(s)™ credits
  • 0.25 Nursing Contact Hours credits
  • 0.25 Non-physician credits
This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing...
AHA 2017: Applying PCSK9 Inhibitors to Improve Outcomes and the Overall Quality...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This Elsevier Conference Reporter will cover data presented at the American Heart Association (AHA) Scientific Session 2017 held in Anaheim, CA. The expert faculty will discuss the role of PCSK9 inhibitors for the treatment of dyslipidemia including achieving LDL-C goals, cardiovascular risk reduction and managing special patient populations....
The IO Quiz Show: Biomarkers for Immunotherapy
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
The IO Quiz Show: Biomarkers for Immunotherapy - Live CME Dinner SymposiumClick here to registerLive CME Dinner SymposiumFriday, January 26, 20186:30 – 7:00 PM: Dinner Buffet7:00 – 8:30 PM: Scientific session San Francisco Marriott MarquisYerba Buena Ballroom, Salon 1-6, Lover B2 LevelSan Francisco, CA 94103FACULTYNaiyer A. Rizvi, MD (chair)...
The LSD Exchange: Optimizing Diagnosis and Future Managment - Live CME Dinner SymposiumClick here to registerLive CME Dinner SymposiumWednesday, February 7, 2018A dinner buffet will be served before the scientific session.6:30 – 7:30 PM: Scientific sessionManchester Grand HyattSeaport Ballroom A1 Market PlaceSan Diego, CA 92101USA FACULTYDavid G....
Applying PCSK9 Inhibitors to Optimize Outcomes in Patients with Dyslipidemia
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
The content for this activity is derived from a live symposium titled, “Applying PCSK9 Inhibitors to Optimize Outcomes in Patients With Dyslipidemia” presented at the American Heart Association Scientific Sessions 2017 in Anaheim, California. This CME activity will highlight optimal treatment and management strategies for patients with...
The Emerging Role of CFTR Combination Regimens in Improving Outcomes for...
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Nursing Contact Hours credits
  • 1.50 Non-physician credits
The content for this activity is based on the live, inter professional seminar titled, “The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis” that was presented at the 31st Annual North American Cystic Fibrosis Conference in Indianapolis, Indiana. This CME/CNE activity will highlight the latest...
Future Perspectives in SMA Management – Current and Emerging Strategies
  • 1.25 AMA PRA Category 1 Credit(s)™ credits
  • 1.25 Non-physician credits
This webcast was recorded during a satellite symposium at the 46th Child Neurology Society (CNS) Annual Meeting in Kansas, MO, USA, on October 6, 2017. During the symposium, the faculty of leading KOLs in the field provided an overview of the genetics and biology of spinal muscular atrophy (SMA) and addressed the subject of the importance of early...
How Immune Checkpoint Inhibitors Are Changing the Treatment Landscape for...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Metastatic melanoma has a high mortality rate and is refractory to traditional treatments, but recent clinical trials have shown significantly improved patient outcomes with checkpoint inhibitors. However, treating physicians may find its use challenging due to limited clinical experience and confidence in prescribing immunotherapies, especially...
An Update on Emerging S1P Therapeutics for the Management of Patients With...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This CME program will highlight data presented at the 7th Annual Joint ECTRIMS – ACTRIMS Meeting in Paris, France. The three expert faculty will analyze recent therapeutic advances in the treatment and management of multiple sclerosis (MS). The clinical relevance of emerging and emerged trial data, particularly regarding S1P therapeutics, will be...
Register Now - Live CME Dinner Symposium
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
The IO Quiz Show: Biomarkers for ImmunotherapyClick here to register DATE, TIME, LOCACTIONFriday, January 26, 20186:30 PM -- 8:00 PM Dinner Buffet7:00 PM -- 8:30 PM Scientific SessionSan Francisco Marriott MarquisYerba Buena Ballroom, Salon 1-6, Lower B2 LevelSan Francisco, CA, USAFACULTYNaiyer A. Rizvi, MD (Chair)Columbia University Medical...

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.